Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.029 EUR | 0.00% | +16.00% | +90.79% |
Jun. 11 | Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study | CI |
May. 27 | Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 | CI |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
EBIT
Cash or Net Debt
- Stock Market
- Equities
- ACARIX Stock
- 7AC Stock
- Revisions Acarix AB